APA (7th ed.) Citation

F, Z., & Z, L. (2026). Formononetin as a potential therapeutic agent for asthma: Evidence from in vivo and in vitro models of attenuated inflammation via cAMP/PKA pathway inhibition. In vitro cellular & developmental biology. Animal, 62(5), 649. https://doi.org/10.1007/s11626-026-01160-4

Chicago Style (17th ed.) Citation

F, Zhang, and Lai Z. "Formononetin as a Potential Therapeutic Agent for Asthma: Evidence from in Vivo and in Vitro Models of Attenuated Inflammation via CAMP/PKA Pathway Inhibition." In Vitro Cellular & Developmental Biology. Animal 62, no. 5 (2026): 649. https://doi.org/10.1007/s11626-026-01160-4.

MLA (9th ed.) Citation

F, Zhang, and Lai Z. "Formononetin as a Potential Therapeutic Agent for Asthma: Evidence from in Vivo and in Vitro Models of Attenuated Inflammation via CAMP/PKA Pathway Inhibition." In Vitro Cellular & Developmental Biology. Animal, vol. 62, no. 5, 2026, p. 649, https://doi.org/10.1007/s11626-026-01160-4.